Roger G. H. Downer
Nessuna posizione attualmente
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Chotchai Charoenngam | M | 61 |
Asian Institute of Technology
| 26 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Paul J. Schechter | M | 84 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 5 anni |
Eliot Lurier | M | 66 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 3 anni |
Thomas E. Gardner | M | 76 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 2 anni |
Carol L. Amelio | F | 62 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 4 anni |
David Holtz | M | 58 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 2 anni |
Shao Hua Dai | M | 41 |
University of Limerick
| 1 anni |
Drajad Widiyanto | M | 60 |
Asian Institute of Technology
| 1 anni |
Paul Adams | M | - |
University of Limerick
| 1 anni |
John Shinnick | M | - |
University of Limerick
| 4 anni |
John Mescall | M | 43 |
University of Limerick
| 4 anni |
Setiawan Wangsaatmaja | M | 61 |
Asian Institute of Technology
| 2 anni |
Ross Nicholas | M | - |
University of Limerick
| 4 anni |
Kate Madden | F | - |
University of Limerick
| 6 anni |
Elaine Collins | F | - |
University of Limerick
| 4 anni |
Allan Mulrooney | M | - |
University of Limerick
| 4 anni |
Audrey Crummy | F | - |
University of Limerick
| 4 anni |
Shane Clifford | M | - |
University of Limerick
| 4 anni |
Alan Cuddihy | M | - |
University of Limerick
| 4 anni |
Aisling Meehan | F | - |
University of Limerick
| 4 anni |
Paul Kelly | M | - |
University of Limerick
| 4 anni |
Thongphet Chanthanivong | M | 62 |
Asian Institute of Technology
| 2 anni |
Keith James McKnight | M | - |
University of Limerick
| 4 anni |
Thang Minh Nguyen | M | 56 |
Asian Institute of Technology
| 1 anni |
Dwayne McNicholas | M | - |
University of Limerick
| 4 anni |
G. A. Fitch | M | - |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 1 anni |
Neil Carragher | M | 85 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 5 anni |
Richard W. Zahn | M | 73 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 5 anni |
Barry Mark Heck | M | 61 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 13 anni |
Edward Gaj | M | 67 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 3 anni |
David C. McDowell | M | 68 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 4 anni |
Scott H. Gillis | M | 71 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 8 anni |
Katherine J. Turner | M | 70 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 2 anni |
David Wills | M | - |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | - |
Paul Gleeson | M | - |
University of Limerick
| 4 anni |
Irakli Gilauri | M | 48 |
University of Limerick
| 4 anni |
Antoin Russell | M | - |
University of Limerick
| 2 anni |
Alan Dunne | M | - |
University of Limerick
| 2 anni |
Karl-Heinz Rinne | M | - |
University of Limerick
| 5 anni |
Karen Payne | F | - |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | - |
Martin Mellody | M | - |
University of Limerick
| 1 anni |
David Poorvin | M | 76 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 4 anni |
Steve Mason | M | - |
University of Limerick
| 4 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Irlanda | 22 | 51.16% |
Stati Uniti | 16 | 37.21% |
Thailandia | 5 | 11.63% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Roger G. H. Downer
- Contatti personali